United States: FDA Releases Draft Guidance On Section 503B Fees For Drug Compounding Outsourcing Facilities; Details Process For Paying And Calculating Fees

On April 1, 2014, the U.S. Food and Drug Administration (FDA) published notice of its Draft Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act ("Draft Guidance"), which sets forth FDA's current thinking on the annual establishment and reinspection fees under Section 503B, as well as the procedures for submitting fees, for annual fee adjustments and for establishing entitlement to the small business fee reduction.

As detailed in an earlier Duane Morris Alert, Section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA) creates a new FDA-regulated entity called an "outsourcing facility," which is permitted to compound sterile drugs for human use with or without a prescription. Outsourcing facilities are required to register with FDA, comply with Current Good Manufacturing Practices (cGMPs), report adverse events to FDA and make semiannual reports to FDA of the drugs the facility compounds. Outsourcing facilities are also subject to FDA inspections on a risk-based schedule and are required to pay an annual establishment fee, as well as fees for reinspection.

In its Draft Guidance, FDA notes its current thinking on the parameters of calculating these various fees under Section 503B and the procedures for paying them.

Annual Establishment Fee

  • General. Starting in 2015, outsourcing facilities must pay an annual establishment fee and will not be considered registered as an outsourcing facility until the fee is paid. The annual registration for Section 503B facilities will start on October 1 and end on December 31 of the year preceding registration (e.g., fees for 2015 will be paid October 1, 2014, through December 31, 2014). Entities that register as outsourcing facilities prior to October 1, 2014, are not required to pay an annual establishment fee for 2014, but they will be required to pay the 2015 annual fee by December 31, 2014.
  • Procedure. In the Draft Guidance, FDA states that it expects to invoice the annual establishment fee no later than three business days after a facility submits its registration information. Entities should submit their registration information no later than December 10 to ensure that FDA is given sufficient time to review and invoice fees before the end of the registration period.
  • Calculating the Annual Establishment Fee. The annual establishment fee is calculated as $15,000, multiplied by an inflation adjustment factor, plus a small business adjustment factor. The full annual establishment fee must be paid regardless of when an entity registers as an outsourcing facility. For example, if a facility registers in May, which is outside of the October 1 to December 31 registration period, the full establishment fee will still be incurred.
  • Adjustment Factors. An outsourcing facility's annual establishment fee is subject to several adjustments.

    • First, Section 503B requires the annual establishment fee to be adjusted on an annual basis for inflation, which is then compounded every year.1 This is referred to as the inflation adjustment factor.
    • Second, the annual establishment fee may be adjusted for small businesses, referred to as the small business reduction. Facilities that qualify for the small business reduction are required to pay an annual establishment fee of only $5,000 multiplied by the inflation adjustment factor. In order to qualify for the small business reduction, a facility must have $1,000,000 or less in gross annual sales in the 12 months ending on April 1 of the fiscal year immediately preceding the year in which the annual establishment fee is assessed. Under Section 503B, "gross annual sales" means "total worldwide gross annual sales, in United States dollars ... including the sales of all domestic and foreign affiliates of the outsourcing facility."2 Requests for the small business reduction must be made by April 30 of the year preceding the fiscal year for the applicable fee and must be resubmitted on an annual basis.
    • Third, entities that do not qualify for the small business reduction will find their annual establishment fees increased by a small business adjustment factor, which is the total amount lost from each "small business" outsourcing facility, divided by the total number of outsourcing facilities that are not granted a small business reduction. In other words, FDA will recoup the loss from small business reductions from outsourcing facilities that are not eligible for that reduction.

Reinspection Fee

Outsourcing facilities may also be subject to reinspection fees if FDA is required to reinspect the facility. A reinspection is defined as:

[O]ne or more inspections conducted under section 704 subsequent to an inspection conducted under such provision which identified noncompliance materially related to an applicable requirement of this Act, specifically to determine whether compliance has been achieved to [FDA's] satisfaction.

In other words, FDA will charge facilities a fee if it has to visit the facility more than once because of noncompliance identified during prior inspections. The reinspection fee is $15,000 multiplied by the inflation adjustment factor and will be invoiced after the reinspection. Small businesses are not entitled to a reduced reinspection fee and will be charged the full inflation-adjusted reinspection fee. Reinspection fees that are not paid within 30 days will accrue interest and fees until the fee is paid in full.

Effect of Failure to Pay Fees

Failing to pay required fees under Section 503B can have substantially adverse effects on outsourcing facilities. For example, drugs compounded in an outsourcing facility that has not paid the required annual establishment fee are not eligible for the Section 503B exemptions to the New Drug Approval (NDA) process or the adequate directions for use labeling requirements. Moreover, drugs compounded by a facility that has not paid required fees are deemed misbranded and may not be distributed in interstate commerce. Failure to pay the annual establishment fee also means that a facility is not considered an "outsourcing" facility under Section 503B.

Dispute Resolution

If an outsourcing facility seeks to dispute the denial of a small business reduction or believes that a reinspection fee was imposed in error, the facility may request that FDA reconsider the fee. Requests for reconsideration should be made within 30 days after FDA issues its decision with respect to a fee. In the Draft Guidance, FDA recommends that reconsideration requests state the facility's basis for concluding that FDA's decision with respect to a fee was in error, and to submit additional information relevant to the facility's position. The Draft Guidance also states that FDA "expects" to rule on reconsideration requests within four months.

If a request for reconsideration is denied, facilities may then appeal FDA's reconsideration decision. Appeal requests should be made within 30 days of the reconsideration decision and should include the original FDA decision, the request for reconsideration, the reconsideration decision and the facility's arguments in support of the appeal. New information may not be presented in the appeal.

Conclusion

The Draft Guidance is the latest step taken by FDA to implement its new authority under Section 503B, and is a key guidepost for 503B entities when considering whether to apply for Section 503 status. Comments to the Draft Guidance may be submitted by June 2, 2014. FDA is accepting comments electronically at http://www.regulations.gov or in writing to the FDA Division of Dockets Management. Further details on the procedure for submitting comments to the Draft Guidance are available on the FDA's notice in the Federal Register.

If you have any questions about this Alert or would like more information, please contact Rachael G. Pontikes, Elinor L. Hart, any of the attorneys in our Pharmaceutical, Medical Device, Pharmacy & Food industry group or the attorney in the firm with whom you are regularly in contact.

Footnotes

1 Specifically, the inflation adjustment factor is added to the total fee, and the total fee from the preceding year is used to calculate the inflation adjustment factor for the current year.

2 "Affiliate" is further defined as a "business entity that has a relationship with a second business entity if, directly or indirectly—(A) one business entity controls, or has the power to control, the other business entity; or (B) a third party controls, or has power to control, both of the business entities."

This article is for general information and does not include full legal analysis of the matters presented. It should not be construed or relied upon as legal advice or legal opinion on any specific facts or circumstances. The description of the results of any specific case or transaction contained herein does not mean or suggest that similar results can or could be obtained in any other matter. Each legal matter should be considered to be unique and subject to varying results. The invitation to contact the authors or attorneys in our firm is not a solicitation to provide professional services and should not be construed as a statement as to any availability to perform legal services in any jurisdiction in which such attorney is not permitted to practice.

Duane Morris LLP, a full-service law firm with more than 700 attorneys in 24 offices in the United States and internationally, offers innovative solutions to the legal and business challenges presented by today's evolving global markets. Duane Morris LLP, a full-service law firm with more than 700 attorneys in 24 offices in the United States and internationally, offers innovative solutions to the legal and business challenges presented by today's evolving global markets. The Duane Morris Institute provides training workshops for HR professionals, in-house counsel, benefits administrators and senior managers.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

    Disclaimer

    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

    Registration

    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

    Cookies

    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

    Links

    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

    Mail-A-Friend

    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

    Emails

    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

    Security

    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions